AION Diagnostics Ltd Develops Product Pipeline And Commences Preclinical Trials

AION Diagnostics Ltd (AION) today announced that it has developed plans for 15 different potential products, as well as commencing preclinical trials on products in the areas of Imaging and BioSensors. The first of these products is expected to be marketed in 2008. AION has already started discussions with the U.S. Food and Drug Administration (FDA).

MORE ON THIS TOPIC